Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Regulatory databases
Regulatory reports
Market reports
Market Snapshots
Infographics
News analysis
Pricing snapshots
Brand price trackers
Flavour trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • France New report recommends actions for e-cigs…
  • Brazil Opposition parties defend e-cig regulation…
  • United States CARE for Moms Act proposes new e-cig tax…
  • Chile Vape regulation could be equated with tobacco products…
  • Russia Bill amending the Tax Code has been introduced…
  • Portugal Tobacco Law amendment approved in Parliament…
  • Kazakhstan MPs disagree with vape ban proposal…
  • Netherlands Prohibited additives amendment renotifed to EC…
  • United States FDA issues CMP complaints to 22 retailers…
  • New Zealand Deadline for vape product notification is 1st October…
  • Netherlands Vijfheerenlanden to prevent new tobacconists…
  • Germany BVL updates list of notified e-cigs…
View all
News analysis

Californian biotech company aims to market vape-style NRT device in US

Written by || 14th July 2020 || News analysis || Companies | Nicotine | Regulation and Legislation | Technology and Innovation | North America United States

A California-based company is seeking US Food and Drug Administration (FDA) authorisation to market what it calls the first “vapour-style inhalable” nicotine replacement therapy (NRT) device ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents
New views on nicotine: now the FDA is reconsidering NRT, too
Study backs e-cigs over NRT for effective smoking cessation
BAT scientists take on the question of risk assessment for new products

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy.